SAM68 is engaged in the progression of numerous cancers, such as MLL fusion induced leukemia (100), prostate cancer (101), breast cancer (2, 33), colon (102), and renal tumor (34). The gene discussed is KHDRBS1; the disease is breast carcinoma.